The Academy recently released a comprehensive glossary of comparative effectiveness research (CER) terms, which can be used as a resource across a variety of health care settings. The glossary illustrates the breadth and depth of terminology used in CER studies and discussions. To access it, click here.
Comparative effectiveness research can give clinicians, patients, purchasers and policymakers valid information on which to make informed decisions regarding medication use. However, before this can happen, all stakeholders involved must have a working knowledge of the terms being discussed.
AMCP’s new document meets this need. The Comparative Effective Research: Glossary of Terms provides succinct definitions of more than 230 CER-related terms – from “a priori analysis” and “absolute risk difference” to “validity” and “variable.”
“Using this resource, professionals across the health care spectrum will have a common language from which to make important decisions regarding medications,” says Marissa Schlaifer, AMCP’s Director of Pharmacy Affairs. “We are pleased to introduce this important resource to our members and other stakeholders.”
The document is being distributed widely to AMCP members and non-members along with the September issue Journal of Managed Care Pharmacy (JMCP) and is available on the AMCP website at www.amcp.org/CERglossaryofterms/.
The Comparative Effective Research: Glossary of Terms was developed for the Academy by the University of Arizona College of Pharmacy. The document and its production were funded by a sponsorship from Novo Nordisk.